Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection
Background. Hepatitis C is a leading cause of mortality among HIV-infected individuals. Therefore, eradication of HCV in this population is a priority. There are scarce data regarding retreatment efficacy of HIV/ HCV coinfected patients. The aim of our study was to evaluate efficacy, predictors of r...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2013-03-01
|
| Серія: | Annals of Hepatology |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S1665268119313614 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|